- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Retail Clinic Growth Expected Under ACA
A recent Accenture finding projected retail health clinics may grow 25-30% annually in coming years, potentially doubling the number of retail clinics that exist. This expected retail clinic growth is due in part to the number of newly insured patients under the Affordable Care Act. MedPage Today reports:
Hospitals and primary care physicians (PCPs) -- groups that have shunned or been slow to accept retail clinics in the past, calling them competitors rather than accomplices -- are warming to the idea of working with such clinics, according to Accenture, based in Washington.
"A return to more stellar growth rates may now follow, not least as the perception of retail clinics as rivals switches to something more practical," said the report, entitled "Retail Medical Clinics: From Foe to Friend?".
In the early part of this century, such clinics grew at breakneck speed with annual growth hovering around 50% to 150% from 2001 to 2008 -- except in 2005, when growth hit 442%, according to Merchant Medicine, a research and consulting firm.
Read the full story here: http://bit.ly/11CysyS
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
